Friday 6 November 2026 Export XERS’s income statement to Excel — free account

Xeris Biopharma Holdings, Inc.

XERS Healthcare Drug Manufacturers Specialty & Generic

Xeris Biopharma Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $291.8 million, up 43.7% from fiscal 2024.

Revenue: +44.2%
EPS: +1,479.0%
Free cash flow: +93.2%
Total debt: −13.6%

Quarter to September 2026, against a year earlier

15.16 2.08 +15.90%

Follow XERS

Alert me

Market cap: $2.4B
P/E: 0.0×
Fwd P/E: −143×
Dividend yield: —
F-score: 8/9
Altman Z: 0.98
Beneish M: −2.58
Dividend safety: n/a

Overview

Xeris Biopharma Holdings, Inc. (XERS) P/E ratio

Alert me on P/E ratio

Xeris Biopharma Holdings, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 2,139× (January 2026) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/XERS/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Xeris Biopharma Holdings, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/XERS/metrics/pe-ratio">Xeris Biopharma Holdings, Inc. (XERS) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	2,066×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Sep 2026	0.0×	—
Jun 2026	0.0×	—
Mar 2026	78.6×	(96.20%)
Dec 2025	2,066×	—
33 more quarters	Free account

Against its own ten years

Low 0.0× High 2,139×

Ten-year median 0.0×

Current reading's percentile 94

Company	P/E ratio
XERS Xeris Biopharma Holdings, Inc.	n/m
PRGO Perrigo Company plc compare	n/m
BCRX BioCryst Pharmaceuticals, Inc. compare	n/m
ALVO Alvotech compare	n/m
TRLV Trulieve Cannabis Corp. compare	n/m
RGC Regencell Bioscience Holdings Limited compare	n/m
HCM HUTCHMED (China) Limited Sponsored ADR compare	n/m
AMLX Amylyx Pharmaceuticals, Inc. compare	n/m
PBH Prestige Consumer Healthcare Inc. compare	13.2×
Drug Manufacturers Specialty & Generic industry median	20.5×
Healthcare sector median	24.5×
Market median	17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Xeris Biopharma Holdings, Inc. (XERS) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on XERS

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on XERS

Stockrow Weekly